Shawn Leland
Direktor/Vorstandsmitglied bei Fore Biotherapeutics, Inc.
Aktive Positionen von Shawn Leland
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 01.09.2023 | - |
Vorstandsvorsitzender | 01.09.2023 | 29.02.2024 |
Karriereverlauf von Shawn Leland
Ehemalige bekannte Positionen von Shawn Leland
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELEVATION ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 01.01.2019 | 05.01.2023 |
Vorstandsvorsitzender | 18.11.2020 | 05.01.2023 | |
Gründer | 01.01.2019 | 05.01.2023 | |
Corporate Officer/Principal | 01.01.2019 | 18.11.2020 | |
Präsident | 18.11.2020 | 05.01.2023 | |
VERASTEM, INC. | Corporate Officer/Principal | 01.09.2017 | 01.08.2019 |
ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2013 | 01.09.2017 |
Ausbildung von Shawn Leland
Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELEVATION ONCOLOGY, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
- Börse
- Insiders
- Shawn Leland
- Erfahrung